Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
The Role of MicroRNA-137 in the Development of a Schizophrenia-like Phenotype in Mice
FY 2013-14
Summary
Recent studies show a connection between microRNA-137, also called miR137, and schizophrenia. Researchers have found that errors in the miR137 gene are linked to an increased risk of schizophrenia. Also, patients with these errors tend to develop the disorder earlier. We hypothesize that miR137 plays a developmental role in schizophrenia.
MicroRNAs such as miR137 are part of a molecular search and destroy machine called the RISC complex. RISC targets mRNAs, which are messenger molecules that relay information from the genome to the rest of the cell. MiR137 acts like a molecular bar code reader. It scans target mRNAs for a matching code and binds to them, leading to their destruction by the RISC complex. Many different mRNAs possess the miR137 target code. Hence, miR137 has the ability to influence multiple genes that impact the development of schizophrenia.
While previous studies implicate miR137 in schizophrenia, better evidence is needed to show a causal relationship. I will explore the potential developmental role of miR137 in schizophrenia by studying genetically modified mice that are not capable of making miR137 in their brains. I will look for abnormal behaviors in these mice that mimic human symptoms of schizophrenia. Also, I will examine how a lack of miR137 influences gene expression and brain structure in these mice. This will reveal important information about the function of miR137 as it relates to schizophrenia, and provide evidence that miR137 is involved in the development of the disorder.
Progress in the development of better treatments for schizophrenia has been slowing in recent years. This is bad news for the 250 000 Canadians living with the disorder. Part of the problem is a lack of understanding about how schizophrenia works. My research will give us important insights into a potential mechanism underlying the disorder. This could lead to the development of new medications which target the miR137 pathway, and potentially help the thousands of people living with schizophrenia
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
311715
Name
Samsom James
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Role of MicroRNA-137 in the Development of a Schizophrenia-like Phenotype in Mice
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Behavior; Immunohistochemistry; Microrna; Mouse Model; Rt-Pcr; Schizophrenia; Transgenic
Abstract
Recent studies show a connection between microRNA-137, also called miR137, and schizophrenia. Researchers have found that errors in the miR137 gene are linked to an increased risk of schizophrenia. Also, patients with these errors tend to develop the disorder earlier. We hypothesize that miR137 plays a developmental role in schizophrenia.
MicroRNAs such as miR137 are part of a molecular search and destroy machine called the RISC complex. RISC targets mRNAs, which are messenger molecules that relay information from the genome to the rest of the cell. MiR137 acts like a molecular bar code reader. It scans target mRNAs for a matching code and binds to them, leading to their destruction by the RISC complex. Many different mRNAs possess the miR137 target code. Hence, miR137 has the ability to influence multiple genes that impact the development of schizophrenia.
While previous studies implicate miR137 in schizophrenia, better evidence is needed to show a causal relationship. I will explore the potential developmental role of miR137 in schizophrenia by studying genetically modified mice that are not capable of making miR137 in their brains. I will look for abnormal behaviors in these mice that mimic human symptoms of schizophrenia. Also, I will examine how a lack of miR137 influences gene expression and brain structure in these mice. This will reveal important information about the function of miR137 as it relates to schizophrenia, and provide evidence that miR137 is involved in the development of the disorder.
Progress in the development of better treatments for schizophrenia has been slowing in recent years. This is bad news for the 250 000 Canadians living with the disorder. Part of the problem is a lack of understanding about how schizophrenia works. My research will give us important insights into a potential mechanism underlying the disorder. This could lead to the development of new medications which target the miR137 pathway, and potentially help the thousands of people living with schizophrenia
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Samsom, James
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~